Janssen Pharmaceutical K.k.
Clinical trials sponsored by Janssen Pharmaceutical K.k., explained in plain language.
-
New hope for kids with rare lung condition: drug shows promise in small study
Disease control CompletedThis study tested a medicine called macitentan in 7 Japanese children (ages 3 months to 15 years) with pulmonary arterial hypertension, a condition where blood pressure in the lungs is too high. The goal was to see if the drug improves blood flow through the lungs after 24 weeks.…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Japanese study reveals Real-World treatment patterns for rare skin condition
Knowledge-focused CompletedThis study looked at how doctors in Japan treat palmoplantar pustulosis (PPP), a skin condition that causes painful blisters on hands and feet. Researchers tracked 276 people already on systemic therapy to see which treatments they used and how long they stayed on them. The goal …
Sponsor: Janssen Pharmaceutical K.K. • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC